kras mutation and glutathion Targeting KRAS-mutant stomach/colorectal tumors by disrupting the ERK2-p53 complex The Role of KRAS Mutations
The Role of KRAS Mutations in Colorectal Cancer: Biological Insights, Clinical Implications, and Future Therapeutic Perspectives KRAS mutation shown to promote tumor evasion of innate immune surveillance in lung cancer KRAS G12D: The Next Frontier in Cancer Therapy MedChemExpress BRAFV600E in colorectal cancer reduces sensitivity to oxidative stress and promotes site specific metastasis by stimulating glutathione synthesis: Cell Reports Frontiers KRAS mutation: The booster of pancreatic ductal adenocarcinoma transformation and progression KRAS mutation: from undruggable to druggable in cancer Signal Transduction and Targeted Therapy
Pay in 4 interest-free payments of $5.47 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7





